Wolters Kluwer and the Cornea Society launch open access title, Cornea Open

July 14, 2023

What: Wolters Kluwer and the Cornea Society have announced an expansion of their publishing footprint with, with the introduction of Cornea Open – which will allow for immediate and worldwide distribution of basic, translational, and clinical research. Cornea Open is now available as a Gold Open Access Journal, focusing on clinical observations, clinical trials and basic investigations with clinical applicability.

Why: Open access publications are now increasingly requested and/or mandated by international institutions as a fundamental principle to provide direct, unrestricted, free-of-charge, and permanent access to articles. This is done to provide benefits to stakeholders in research publishing, including the researchers, funders, students, librarians, publishers, and the public. This immediate accessibility accelerates dissemination of the most recent scientific, research, and medical evidence.

Who: The Cornea Society, which also publishes Cornea with Wolters Kluwer, is dedicated to promoting the exchange of information in cornea and external disease internationally.

Bennie H. Jeng, MD, Editor-in-Chief of Cornea Open shared: “Bringing an open access title to the Cornea Society’s portfolio presents an amazing opportunity to move forward the research and information available to eye specialists across the globe. While Cornea will continue to be our flagship journal, Cornea Open will bring forth unique and important basic research, clinical research, techniques, and case reports related to diseases of and medical and surgical treatment of the cornea and external eye that are not directly related to corneal transplantation and eye banking. We invite all readers, regardless of whether you are a clinician, student, or a follower of our industry to contribute to this new, expanded journal.”

How:

• Learn more about Cornea Open and read the latest issue, here.
• To become an author, head to journal’s site and review the “Online Submission and Review Systems” section.
  • Additionally, there is an editorial manager link for, here.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

###

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2022 annual revenues of €5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Twitter, Facebook, and YouTube.